Skip to main content Accessibility help
×
Home

Pulse therapy combined with oral corticosteroids in the management of severe rheumatic carditis and rebound

  • Renato P. A. Torres (a1), Rômulo F. A. Torres (a2), Rafael A. Torres (a3) and Rosângela S. L. A. Torres (a4)

Abstract

Objective

The aim of the present study was to describe the clinical course, laboratory tests, and the cardiac involvement in rheumatic carditis patients in functional class III and IV, submitted to pulse therapy combined with oral prednisone.

Methods

A total of 120 patients with severe carditis due to acute rheumatic fever were treatment with three cycles of pulse therapy combined with oral corticosteroids. The patients were followed up from the hospital admission until the end of the treatment and returned after 30, 60, and 90 days to control. The patients were evaluated by clinical, laboratory, and transthoracic echocardiogram.

Results

In total, 23 (19.2%) patients at first attack of rheumatic fever and 97 (80.8%) with recurrent carditis were evaluated. Cardiac surgery was performed in 8 (6.6%) patients. The patients showed improved laboratory and radiological parameters (p<0.001) and were discharged, 74 (61.7%) in functional class I and 46 (38.3%) in functional class II. Hospitalisation time ranged from 21 to 176 days, with a mean of 69.1 days. Reduction of left atrium and ventricle diameters was observed, measured by means of transthoracic echocardiography, at hospital admission and discharge (p<0.001). None of the patients experienced rebound.

Conclusions

The pulse therapy was effective in controlling severe rheumatic carditis and the oral corticosteroid prevented rebound episodes. Prolonged hospital stay was required for the clinical stabilisation of patients and to avoid the interruption of medication.

Copyright

Corresponding author

Correspondence to: R. S. L. A. Torres, MS, PhD, Universidade Positivo, Rua Professor Pedro Viriato Parigot de Souza, Campina do Siqueira, CEP 80740-050, Curitiba, PR, Brazil. Tel: 55 41 991941237; Fax: 55 41 33101283; E-mail: rslatorres@gmail.com

References

Hide All
1. WHO. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation on rheumatic fever and rheumatic heart disease. World Health Organization. Geneva, 2001, Oct 29–Nov 1. Geneva: WHO, 2004.
2. Gewitz, MH, Baltmore, RS, Tani, LY, et al. On behalf of the American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation 2015; 131: 18061818.
3. Carapetis, JR, Steer, AC, Mulholland, EK, et al. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5: 685694.
4. Steer, AC, Carapetis, JR, Nolan, TM, et al. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child Health 2002; 38: 229234.
5. Czoniczer, G, Amezcua, F, Pellargonio, S, et al. Therapy of severe rheumatic carditis. Comparison of adrenocortical steroids and aspirin. Circulation 1964; 29: 813819.
6. Torres, RSLA, Torres, RPA, Smeesters, PR, et al. Group A Streptococcus antibiotic resistance in southern Brazil: a 17-year surveillance study. Microb Drug Resist 2011; 17: 313319.
7. Kumar, RK, Tandon, R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J Med Res 2013; 137: 643658.
8. Cilliers, A, Adler, AJ, Saloojee, H. Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev 2015; 5: 156.
9. Couto, AA, Martins, JC, Mansur, EM, et al. High-dose intravenous methylprednisolone (pulsetherapy): possible therapeutic solution for active rheumatic fever with severe carditis. Arq Bras Cardiol 1984; 43: 97101.
10. Markowitz, M, Gordis, L. Rheumatic fever. Major Probl Clin Pediatr 1972; 11: 1309.
11. Herdy, GV, Couto, AA, Fernandes, JC, et al. Pulse therapy (high venous of venous methylprednisolone) in children with rheumatic carditis. Prospective study of 40 episodes. Arq Bras Cardiol 1993; 60: 377381.
12. Herdy, GV, Pinto, CA, Olivaes, MC, et al. Rheumatic carditis treated with high doses of pulsetherapy methylprednisolone. Results in 70 children over 12 years. Arq Bras Cardiol 1999; 72: 604606.
13. Akçoral, A, Oran, B, Tavli, V, et al. Effects of high-dose intravenous methylprednisolone in children with acute rheumatic carditis. Acta Paediatr Jpn 1996; 38: 2831.
14. Camara, EJN, Braga, JCV, Alves-silva, LS, et al. Comparison of an intravenous pulse of methylprednisolone versus oral corticosteroid in severe acute rheumatic carditis: a randomized clinical trial. Cardiol Young 2002; 12: 119124.
15. Ilingworth, RS, Burke, J, Doxiadis, SA, et al. Salicylates in rheumatic fever: an attempt to assess their value. Q J Med 1954; 23: 177213.
16. UK and US Joint Report. The natural history of rheumatic fever and rheumatic heart disease: cooperative clinical trial of ACTH, cortisone, and aspirin. Circulation 1965; 32: 457476.
17. Illingworth, RS, Lorber, J, Holt, KS, et al. Acute rheumatic fever in children: a comparison of six forms of treatment in 200 cases. Lancet 1957; 273: 653659.
18. Bywaters, EG, Thomas, GT. Bed rest, salicylates, and steroid in rheumatic fever. Br Med J 1961; 1: 16281634.
19. Paz, JA, Silva, CA, Marques-Dias, MJ. Randomized double-blind study with prednisone in Sydenham’s chorea. Pediatr Neurol 2006; 34: 264269.
20. Walker, AR, Tani, LY, Thompson, JA, et al. Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids. J Pediatr 2007; 151: 679683.
21. Fusco, C, Ucchino, V, Frattini, D, et al. Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham’s chorea. Eur J Paediatr Neurol 2012; 16: 373378.
22. Bitar, FF, Hayek, P, Obeid, M, et al. Rheumatic fever in children: a 15-year experience in a developing country. Pediatr Cardiol 2000; 21: 119122.
23. Little, SG. The challenges of managing rheumatic disease of the mitral valve in Jamaica. Cardiol Young 2014; 24: 11081110.
24. Torres, RPA, Cunha, CLP, Miyague, NI. Estudo de 500 casos de febre reumática na cidade de Curitiba. Divulgação em Saúde para Debate 2000; 19: 7375.

Keywords

Pulse therapy combined with oral corticosteroids in the management of severe rheumatic carditis and rebound

  • Renato P. A. Torres (a1), Rômulo F. A. Torres (a2), Rafael A. Torres (a3) and Rosângela S. L. A. Torres (a4)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed